Auto Injectors Market - Forecast(2021 - 2026)

Report Code: HCR 58467 Report Format: PDF + Excel (Delivery in 48 Hrs)

Auto Injectors Market Overview

Auto Injectors Market size is estimated at $45.4 billion in 2020, projected to grow at a CAGR of 17.4% during the forecast period 2021-2026. An auto-injector is a small pen-shaped device with a hypodermic needle that is used to administer a set dosage of medication to patients. The medicine is administered by placing the prefilled syringe hypodermic needle in the appropriate injection site and pressing a button. The optimal route of administration is intramuscular, but the location of injection is normally determined by the nature of the medication to be administered. Epinephrine auto-injectors are often used for people who are at risk of anaphylaxis.

In the military, auto-injectors are often used to shield personnel from chemical weapons agents. The rising prevalence of multiple sclerosis (MS) is driving the Auto Injectors industry. According to a report released in February 2019 in the journal Neurology by the National MS Society, almost 1 million adults in the United States had MS in 2017. The majority of these auto-injector systems are prefilled, spring-loaded prefilled syringes, hypodermic needle that are used to treat severe allergic reactions such as anaphylaxis or anaphylactic shock, as well as rheumatoid arthritis and multiple sclerosis. Auto-Injectors are simple to use and are designed for patients or other caretakers or staff to administer themselves at home through various route of administration like Intramuscular and Subcutaneous.

Auto Injectors Market Report Coverage

The report: “Auto Injectors Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Auto Injectors Market.
By Type: Disposable and Reusable - Prefilled Auto Injectors and Empty Auto Injectors.
By Disease Indication: Multiple Sclerosis, Anaphylaxis, Rheumatoid Arthritis, Diabetes and Cardiovascular Diseases.
By Route of Administration: Intramuscular and Subcutaneous.
By End Use: Hospitals/Clinics, Ambulatory Surgical Centers and Homecare.
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia & New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and Rest of South America) and RoW (Middle East and Africa).

Key Takeaways


Auto Injectors Market: Market Share (%) by Region, 2020

Auto Injectors Market
For More Details on This Report - Request for Sample

Auto Injectors Market Segment Analysis By Type:

Based on Type, Auto Injectors Market is segmented into Disposable and Reusable – Prefilled Auto Injectors and Empty Auto Injectors. Disposable accounted for the largest revenue market share in 2020 owing towards increased patient awareness and propensity toward self-administration, growing demand for auto-injectors due to rising prevalence of anaphylaxis and other emergency conditions, hypodermic needle, and easy-to-use disposable auto-injectors. The ease of use and the availability of a built-in glass prefilled syringe (which removes the need to manually fill the glass prefilled syringe), disposable auto injectors is used among patients with decreased dexterity or visual impairments driving the segment growth. Reusable segment is anticipated to grow with the fastest CAGR of 17.9% in the forecast period 2021-2026 as it minimizes both manufacturers and patient’s storage and waste footprints, lowering environmental effects thereby, driving the Auto Injectors Industry.

Auto Injectors Market Segment Analysis – Application:

Based on Application, Auto Injectors Market is segmented into Multiple Sclerosis, Anaphylaxis, Rheumatoid Arthritis, Diabetes and Cardiovascular Diseases. Rheumatoid Arthritis accounted for the largest revenue market share in 2020. In 2019, the demand for auto injectors was dominated by rheumatoid arthritis. The high prevalence of this category accounts for large share. According to the CDC, arthritis, RA, gout, lupus, and fibromyalgia affect an estimated 43.7 million people (22.7 percent of the total population) in the United States each year. The demand is growing due to an increase in the occurrence of anaphylactic shock, as well as government support for allowing the instrument to be sold in different locations, resulting in Auto Injectors Industry growth. Multiple Sclerosis segment is anticipated to grow with the fastest CAGR of 18.1% during the forecast period 2021-2026. Although there is no cure for MS, general treatment focuses on a quick recovery from injury, which slows disease progression and manages MS symptoms. The growing demand for better multiple sclerosis hypodermic needle auto injector options would result in manufacturers introducing new products into the market, which boost demand, as well as rising government measures, thereby, expanding the Auto Injectors Market.

Auto Injectors Market Segment Analysis - By Geography:

Based on Geography, North America Auto Injectors Market accounted for the 39% revenue share in 2020 owing towards the rising prevalence of anaphylaxis and food allergies, as well as rapid technical advances in the healthcare field in this region. According to the American Academy of Pediatrics, almost 5.6 million children in the United States had food allergies in 2018, with less than half having access to an epinephrine hypodermic needle auto-injector prescription. Milk, peanut butter, and shellfish are the most common food allergies. The high prevalence of cardiovascular diseases, especially in the United States, will provide numerous opportunities for companies operating in this region to expand. The major players are working on modern Auto Injectors systems that are technologically advanced. According to the World Health Organization (WHO), an estimated 26 million people in the United States suffered from allergies, and an estimated 400,000 people in the United States and 2.5 million people worldwide suffered from multiple sclerosis in 2015, with over 400 new cases of multiple sclerosis being found per week in the United States, according to Healthline Networks, is accelerating Auto Injectors Industry expansion across the region. Asia-Pacific is predicted to be the fastest growing region during the forecast period 2021- 2026 owing towards the large diabetes population and increasing healthcare expenditure.

Auto Injectors Market Drivers

The Increasing Prevalence Of Anaphylaxis:

The market is anticipated to develop owing the rising incidences of Anaphylaxis. Anaphylaxis reactions affect one in every 1,000 people, according to a NICE report. During general anaesthesia, anaphylaxis occurs in 1 in 10,000–20,000 anaesthetics. If a safe combination of drugs can be found, these patients will be refused general anaesthesia in the future. Anaphylaxis has an annual occurrence rate of 1.5–50 per 100,000 person-years, according to epidemiological studies. According to a 2019 report reported in the European Journal of Allergy and Clinical Immunology, the global incidence of anaphylaxis in children ranged from 1 to 761 per 100,000 person-years for overall anaphylaxis and 1 to 77 per 100,000 person-years for food-related anaphylaxis. For anaphylaxis, pharmaceutical companies are developing technologically advanced epinephrine hypodermic needle auto injectors (EAIs), aiding growth towards the Auto Injectors Industry.

Auto Injectors Market Challenges

Advancement Of Auto Injectors For Multiple Drug Viscosities:

OEMs face the most difficult task in designing single-design auto injectors for a variety of drugs and biologics with varying viscosities. To produce a spring rate that provides enough power to push higher-viscosity drugs and biologics through the prefilled syringe to the hypodermic needle, springs with different physical characteristics such as structure, length, and thickness are needed. Many pharmaceutical companies currently lack the expertise needed to develop auto injectors that can deliver multiple drugs and biologics with varying viscosities are expected to limit the Auto Injectors industry growth. Since patients with diabetes, rheumatoid arthritis, and growth hormone deficiency, among other conditions, need weekly injection therapy with auto injectors, hypodermic needle anxiety is a major stumbling block to market expansion. Furthermore, the market's growth is expected to be hampered by the market's strict regulatory environment for auto-injector approval. The U.S. FDA classifies auto-injectors as class II high-risk medical devices and is subject to additional control prior to obtaining approval.

Auto Injectors Market Landscape:

The Auto Injectors Market's main strategies include product launches, mergers and acquisitions, joint ventures, and regional expansion. Auto Injectors Market top 10 companies are Janssen Global Services, LLC, Antares Pharma, Inc., Amgen Inc., Becton, Dickinson and Company, Sanofi, Pfizer, Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Novartis International AG, Bayer AG and Eli Lilly and Company.

Acquisitions/Product Launches:

  • In January, 2021, Eli Lilly and Company acquired Prevail Therapeutics Inc. Prevail's portfolio of clinical-stage and preclinical neuroscience assets will serve as the foundation for Lilly's new gene therapy program, which will be anchored by the company's clinical-stage and preclinical neuroscience assets.
  • In April, 2020, Teva Pharmaceutical Industries Ltd launched autoinjector system for the injection of AJOVY® (fremanezumab-vfrm) in U.S. AJOVY is the only anti-CGRP migraine medication with quarterly and monthly subcutaneous dosing options, and is recommended for the prevention of migraine in adults.

Related Reports

Report Code: HCR 0023

Report Code: HCR 0718

For more Lifesciences and Healthcare Market reports - Please click here

1. Auto Injectors Market - Overview
    1.1 Definitions and Scope
2. Auto Injectors Market - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends by Type
    2.3 Key trends by Disease Indication
    2.4 Key trends by Geography
3. Auto Injectors Market - Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis– Key Companies
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. Auto Injectors Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Auto Injectors Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Auto Injectors Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Auto Injectors Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Auto Injectors Market – By Type (Market Size –$Million/$Billion)
    8.1 Disposable
    8.2 Reusable
        8.2.1 Prefilled Auto Injectors
        8.2.2 Empty Auto Injectors
9. Auto Injectors Market – By Disease Indication (Market Size –$Million/$Billion)
    9.1 Multiple Sclerosis
    9.2 Anaphylaxis
    9.3 Rheumatoid Arthritis
    9.4 Diabetes
    9.5 Cardiovascular Diseases
10. Auto Injectors Market – By Route Of Administration (Market Size –$Million/$Billion)
    10.1 Intramuscular
    10.2 Subcutaneous
11. Auto Injectors Market – By End Use (Market Size –$Million/$Billion)
    11.1 Hospitals/Clinics
    11.2 Ambulatory Surgical Centers
    11.3 Homecare
12. Auto Injectors Market - By Geography (Market Size –$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Canada
        12.1.3 Mexico
    12.2 Europe
        12.2.1 U.K.
        12.2.2 Germany
        12.2.3 France
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia-Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia-Pacific
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Rest of South America
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. Auto Injectors Market - Entropy
14. Auto Injectors Market – Industry/Segment Competition Landscape Premium 
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Countries – Key Companies
        14.1.4 Best Practices for Companies
15. Auto Injectors Market – Key Company List by Country Premium Premium
16. Auto Injectors Market Company Analysis
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Auto Injectors Market Analysis and Forecast, By Product Type Market 2019-2024 ($M)
1.1 By Product Type Market 2019-2024 ($M) - Global Industry Research
1.1.1 Prefilled Auto Injectors Market 2019-2024 ($M)
1.1.2 Fillable Auto Injectors Market 2019-2024 ($M)
2.Global Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2019-2024 ($M)
2.1 By Therapeutic Area Market 2019-2024 ($M) - Global Industry Research
2.1.1 Anaphylaxis Market 2019-2024 ($M)
2.1.2 Multiple Sclerosis Market 2019-2024 ($M)
2.1.3 Rheumatoid Arthritis Market 2019-2024 ($M)
3.Global Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2019-2024 ($M)
3.1 By Distribution Channel Market 2019-2024 ($M) - Global Industry Research
3.1.1 Hospital Pharmacies Market 2019-2024 ($M)
3.1.2 Retail Pharmacies Market 2019-2024 ($M)
3.1.3 Online Pharmacies Market 2019-2024 ($M)
3.1.4 Drug Stores Market 2019-2024 ($M)
4.Global Competition Landscape Market 2019-2024 ($M)
5.Global Auto Injectors Market Analysis and Forecast, By Product Type Market 2019-2024 (Volume/Units)
5.1 By Product Type Market 2019-2024 (Volume/Units) - Global Industry Research
5.1.1 Prefilled Auto Injectors Market 2019-2024 (Volume/Units)
5.1.2 Fillable Auto Injectors Market 2019-2024 (Volume/Units)
6.Global Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2019-2024 (Volume/Units)
6.1 By Therapeutic Area Market 2019-2024 (Volume/Units) - Global Industry Research
6.1.1 Anaphylaxis Market 2019-2024 (Volume/Units)
6.1.2 Multiple Sclerosis Market 2019-2024 (Volume/Units)
6.1.3 Rheumatoid Arthritis Market 2019-2024 (Volume/Units)
7.Global Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2019-2024 (Volume/Units)
7.1 By Distribution Channel Market 2019-2024 (Volume/Units) - Global Industry Research
7.1.1 Hospital Pharmacies Market 2019-2024 (Volume/Units)
7.1.2 Retail Pharmacies Market 2019-2024 (Volume/Units)
7.1.3 Online Pharmacies Market 2019-2024 (Volume/Units)
7.1.4 Drug Stores Market 2019-2024 (Volume/Units)
8.Global Competition Landscape Market 2019-2024 (Volume/Units)
9.North America Auto Injectors Market Analysis and Forecast, By Product Type Market 2019-2024 ($M)
9.1 By Product Type Market 2019-2024 ($M) - Regional Industry Research
9.1.1 Prefilled Auto Injectors Market 2019-2024 ($M)
9.1.2 Fillable Auto Injectors Market 2019-2024 ($M)
10.North America Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2019-2024 ($M)
10.1 By Therapeutic Area Market 2019-2024 ($M) - Regional Industry Research
10.1.1 Anaphylaxis Market 2019-2024 ($M)
10.1.2 Multiple Sclerosis Market 2019-2024 ($M)
10.1.3 Rheumatoid Arthritis Market 2019-2024 ($M)
11.North America Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2019-2024 ($M)
11.1 By Distribution Channel Market 2019-2024 ($M) - Regional Industry Research
11.1.1 Hospital Pharmacies Market 2019-2024 ($M)
11.1.2 Retail Pharmacies Market 2019-2024 ($M)
11.1.3 Online Pharmacies Market 2019-2024 ($M)
11.1.4 Drug Stores Market 2019-2024 ($M)
12.North America Competition Landscape Market 2019-2024 ($M)
13.South America Auto Injectors Market Analysis and Forecast, By Product Type Market 2019-2024 ($M)
13.1 By Product Type Market 2019-2024 ($M) - Regional Industry Research
13.1.1 Prefilled Auto Injectors Market 2019-2024 ($M)
13.1.2 Fillable Auto Injectors Market 2019-2024 ($M)
14.South America Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2019-2024 ($M)
14.1 By Therapeutic Area Market 2019-2024 ($M) - Regional Industry Research
14.1.1 Anaphylaxis Market 2019-2024 ($M)
14.1.2 Multiple Sclerosis Market 2019-2024 ($M)
14.1.3 Rheumatoid Arthritis Market 2019-2024 ($M)
15.South America Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2019-2024 ($M)
15.1 By Distribution Channel Market 2019-2024 ($M) - Regional Industry Research
15.1.1 Hospital Pharmacies Market 2019-2024 ($M)
15.1.2 Retail Pharmacies Market 2019-2024 ($M)
15.1.3 Online Pharmacies Market 2019-2024 ($M)
15.1.4 Drug Stores Market 2019-2024 ($M)
16.South America Competition Landscape Market 2019-2024 ($M)
17.Europe Auto Injectors Market Analysis and Forecast, By Product Type Market 2019-2024 ($M)
17.1 By Product Type Market 2019-2024 ($M) - Regional Industry Research
17.1.1 Prefilled Auto Injectors Market 2019-2024 ($M)
17.1.2 Fillable Auto Injectors Market 2019-2024 ($M)
18.Europe Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2019-2024 ($M)
18.1 By Therapeutic Area Market 2019-2024 ($M) - Regional Industry Research
18.1.1 Anaphylaxis Market 2019-2024 ($M)
18.1.2 Multiple Sclerosis Market 2019-2024 ($M)
18.1.3 Rheumatoid Arthritis Market 2019-2024 ($M)
19.Europe Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2019-2024 ($M)
19.1 By Distribution Channel Market 2019-2024 ($M) - Regional Industry Research
19.1.1 Hospital Pharmacies Market 2019-2024 ($M)
19.1.2 Retail Pharmacies Market 2019-2024 ($M)
19.1.3 Online Pharmacies Market 2019-2024 ($M)
19.1.4 Drug Stores Market 2019-2024 ($M)
20.Europe Competition Landscape Market 2019-2024 ($M)
21.APAC Auto Injectors Market Analysis and Forecast, By Product Type Market 2019-2024 ($M)
21.1 By Product Type Market 2019-2024 ($M) - Regional Industry Research
21.1.1 Prefilled Auto Injectors Market 2019-2024 ($M)
21.1.2 Fillable Auto Injectors Market 2019-2024 ($M)
22.APAC Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2019-2024 ($M)
22.1 By Therapeutic Area Market 2019-2024 ($M) - Regional Industry Research
22.1.1 Anaphylaxis Market 2019-2024 ($M)
22.1.2 Multiple Sclerosis Market 2019-2024 ($M)
22.1.3 Rheumatoid Arthritis Market 2019-2024 ($M)
23.APAC Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2019-2024 ($M)
23.1 By Distribution Channel Market 2019-2024 ($M) - Regional Industry Research
23.1.1 Hospital Pharmacies Market 2019-2024 ($M)
23.1.2 Retail Pharmacies Market 2019-2024 ($M)
23.1.3 Online Pharmacies Market 2019-2024 ($M)
23.1.4 Drug Stores Market 2019-2024 ($M)
24.APAC Competition Landscape Market 2019-2024 ($M)
25.MENA Auto Injectors Market Analysis and Forecast, By Product Type Market 2019-2024 ($M)
25.1 By Product Type Market 2019-2024 ($M) - Regional Industry Research
25.1.1 Prefilled Auto Injectors Market 2019-2024 ($M)
25.1.2 Fillable Auto Injectors Market 2019-2024 ($M)
26.MENA Auto Injectors Market Analysis and Forecast, By Therapeutic Area Market 2019-2024 ($M)
26.1 By Therapeutic Area Market 2019-2024 ($M) - Regional Industry Research
26.1.1 Anaphylaxis Market 2019-2024 ($M)
26.1.2 Multiple Sclerosis Market 2019-2024 ($M)
26.1.3 Rheumatoid Arthritis Market 2019-2024 ($M)
27.MENA Auto Injectors Market Analysis and Forecast, By Distribution Channel Market 2019-2024 ($M)
27.1 By Distribution Channel Market 2019-2024 ($M) - Regional Industry Research
27.1.1 Hospital Pharmacies Market 2019-2024 ($M)
27.1.2 Retail Pharmacies Market 2019-2024 ($M)
27.1.3 Online Pharmacies Market 2019-2024 ($M)
27.1.4 Drug Stores Market 2019-2024 ($M)
28.MENA Competition Landscape Market 2019-2024 ($M)

LIST OF FIGURES

1.US Auto Injectors Market Revenue, 2019-2024 ($M)
2.Canada Auto Injectors Market Revenue, 2019-2024 ($M)
3.Mexico Auto Injectors Market Revenue, 2019-2024 ($M)
4.Brazil Auto Injectors Market Revenue, 2019-2024 ($M)
5.Argentina Auto Injectors Market Revenue, 2019-2024 ($M)
6.Peru Auto Injectors Market Revenue, 2019-2024 ($M)
7.Colombia Auto Injectors Market Revenue, 2019-2024 ($M)
8.Chile Auto Injectors Market Revenue, 2019-2024 ($M)
9.Rest of South America Auto Injectors Market Revenue, 2019-2024 ($M)
10.UK Auto Injectors Market Revenue, 2019-2024 ($M)
11.Germany Auto Injectors Market Revenue, 2019-2024 ($M)
12.France Auto Injectors Market Revenue, 2019-2024 ($M)
13.Italy Auto Injectors Market Revenue, 2019-2024 ($M)
14.Spain Auto Injectors Market Revenue, 2019-2024 ($M)
15.Rest of Europe Auto Injectors Market Revenue, 2019-2024 ($M)
16.China Auto Injectors Market Revenue, 2019-2024 ($M)
17.India Auto Injectors Market Revenue, 2019-2024 ($M)
18.Japan Auto Injectors Market Revenue, 2019-2024 ($M)
19.South Korea Auto Injectors Market Revenue, 2019-2024 ($M)
20.South Africa Auto Injectors Market Revenue, 2019-2024 ($M)
21.North America Auto Injectors By Application
22.South America Auto Injectors By Application
23.Europe Auto Injectors By Application
24.APAC Auto Injectors By Application
25.MENA Auto Injectors By Application